Range Cancer Therapeutics ETF (NASDAQ: CNCR)

Latest News for Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Loncar Cancer Immunotherapy ETF

Biotech

Long Ideas

Sector ETFs

Health Care

Trading Ideas

ETFs

General

BTEC

CNCR

IDNA

MRNA

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

3 ETFs For More Moderna Bets

News

New ETFs

Emerging Market ETFs

BGNE

CBPO

CHNA

KURE

Hone In On Health Care In China With This New ETF

Range Cancer Therapeutics ETF

Cantor Fitzgerald analyst Mike Kozak upgrades Caledonia Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CMCL#AMEX">CMCL</a>) from Hold to Speculative Buy and announces $13.5 price target.

Upgrades

Price Target

Analyst Ratings

CMCL

Cantor Fitzgerald Upgrades Caledonia Mining to Speculative Buy, Announces $13.5 Price Target

Citigroup analyst Ryan Levine initiates coverage on Pinnacle West Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNW#NYSE">PNW</a>) with a Neutral rating and announces Price Target of $78.

Initiation

Citigroup Initiates Coverage On Pinnacle West Capital with Neutral Rating, Announces Price Target of $78

<ul>
<li>TSLA</li>
<li>SOFI</li>
<li>NVDA</li>
<li>AAPL</li>
<li>FSD</li>
<li>IBRX</li>
<li>AMD</li>
<li>AMZN</li>
<li>META</li>
<li>AI</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

AMZN

IBRX

NVDA

SOFI

TSLA

Top 10 Trending Stocks On WallStreetBets As Of April 29, 2024 (Via Swaggy Stocks)

<a href="https://www.benzinga.com/cannabis">Cannabis consumers</a>, often stigmatized as lazy or spaced out, are finding vindication in a new study from the University of Toronto (U of T) Scarborough that challenges these negative stereotypes.
"There is a stereotype that chronic cannabis users are somehow lazy or unproductive," says Michael Inzlicht, a professor in the Department of Psychology at U of T Scarborough who led the study.
"We found that's not the case — their behaviors might change a bit in the moment while they're high, but our evidence shows they are not lazy or lacking motivation at all,&#8221; Inzlicht adds.
The research surveyed the lives of 260 frequent cannabis consumers. It found no significant drop in their motivation or effort levels while high compared to when they were not high.
Published on April 23 in the journal Social Psychological and Personality Science, the <a href="https://journals.sagepub.com/doi/10.1177/19485506241245744">study</a> scrutinizes the impact of cannabis on daily life.
Past research has shown mixed results when it comes to chronic cannabis use and motivation. Inzlicht notes much of it relied on limited experimental designs that didn't account for differences between cannabis users and non-users, such as variations in personality, mental health or use of other psychoactive substances.
<h2 class="wp-block-heading">Here's What Researchers Found</h2>
Key findings shed light on emotional nuances and self-regulation dynamics. While cannabis provoked heightened positive emotions like awe and gratitude, it also triggered a subtle decline in self-regulation, manifesting as increased impulsivity and disorderliness. However, this dip did not diminish users&#8217; industriousness or focus, challenging misconceptions about their work ethic, Inzlicht <a href="https://neurosciencenews.com/attention-cannabis-psychology-25994/">noted</a> in NeuroscienceNews.com.
"These things can detract someone from getting stuff done, but we didn't find it made them less hard-working, responsible or able to focus."
Contrary to popular belief, participants displayed unwavering motivation, exhibiting consistent effort levels even while high, the survey found.
<h2 class="wp-block-heading">Is &#8216;Weed Hangover&#8217; A Thing?</h2>
The research also found no evidence of the so-called "weed hangover" or decline in emotional or motivational function the day after cannabis use, debunking the hangover idea.
"The cannabis literature, historically, tended to focus a lot on the negative medical consequences of chronic use," said Inzlicht, who runs the Work and Play Lab, which researches self-control, motivation and empathy as well as social media, digital device and recreational cannabis use. 
"Part of the motivation for this study is to take a neutral, clear-eyed approach to see how cannabis affects chronic users in their everyday lives,&#8221; Inzlicht concluded.
Photo: Shutterstock

Cannabis

Psychology

Cannabis Users 'Are Not Lazy Or Lacking Motivation At All' Even While High: University Of Toronto Study

WIIM

IONM

Assure Holdings shares are trading lower after the company said the unaudited financial statements for the quarterly periods ended March 31, 2023, June 30, 2023 and Sept 30, 2023 should no longer be relied on.

Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) ("Antelope Enterprise" or the "Company"),&nbsp;which operates KylinCloud, a livestreaming ecommerce business in China with access to 800,000+ hosts and influencers, announced today that its plan to launch its energy transmission business.The Board appointed Mr. Huoyou Zhang as an Executive Director to the Company's Board of Directors, effective April 26, 2024, and Mr. Di Wu as a Director and President of its operating subsidiary to lead this new business. Also, Mr. Qiguo Wang resigned from the Company's Board, effective April 26, 2024, for personal reasons.
The Company's new business of energy transmission is being operated via its wholly owned subsidiary, AEHL US LLC ("AEHL US"). AEHL US has taken preliminary steps in developing this business including engaging a broker to source natural gas from natural gas provider in Texas and the procurement of electricity generators. AEHL US plans to supply power to a data center in Midland, Texas. The Company anticipates that its energy transmission business will start operation in the third quarter of 2024. The Company also plans to generate revenue by securing hosting sites for cryptocurrency mining operators as it leverages anticipated cost-effective electricity costs.
To spearhead the Company's new business initiative, the Company has retained an experienced leadership team including Mr. Houyou Zhang and Mr. Di Wu. Mr. Houyou Zhang has been appointed to be an Executive Director with responsibility to help formulate and implement the Company's growth strategy for its energy transmission business.
"We welcome Mr. Zhang to our Board and are confident that he will make a positive contribution to the Company. We believe that both Mr. Zhang and Mr. Wu have the knowledge and expertise that will ensure the success of our new energy transmission business," said Chairman and CEO Will Zhang of Antelope Enterprise.
"We believe that there is a prosperous future ahead for the development of what we believe is an innovative electricity supply solution. The boom in the AI industry as well as cryptocurrency mining has led to a gap in the power supply and we believe that we can develop a cost-effective structure to bridge this gap." CEO Will Zhang concluded.&nbsp;
Mr. Houyou Zhang has been appointed to be an Executive Director of the Company with responsibility to help formulate and implement the Company's growth strategy for its energy transmission business, effective April 26, 2024. Mr. Zhang is also a Director at YiXiang International LLC which he has been since March 2023, where he secures projects for investment. From 2017 to 2022, Mr. Zhang was the Chairman of Shanghai KKM Asset Management Co. Ltd., a firm that he founded, which engages in investment and asset management. Mr. Zhang is experienced in quantitative trading in China with 20 years of experience in the finance industry, and he has published widely on finance and investments. Mr. Zhang received a Bachelor's degree in Engineering from Sichuan University in 2002.
Mr. Di Wu is being appointed as the Director and President of AEHL US. Prior to this appointment, Mr. Wu was Deputy General Manager of Shanghai Kunjing Cloud Co., Ltd. Since 2020, where he was responsible for mobile charging energy storage, its EV charging business and has participated in edge computing data centers and an Internet of Things aggregation business. From 2016 to 2020, Mr. Wu was Deputy General Manager of Wuxi Chenyun Technology Co., Ltd., where he was in charge of operations and cloud business product design. Mr. Wu currently indirectly owns 14.33% of Class A ordinary shares, no par value, of the Company. Mr. Wu received an MBA from Nanjing University of Finance and Economics in 2002.
Mr. Qiguo Wang, a director of the Company's Board, tendered his resignation effective April 26, 2024. Mr. Wang's resignation was for personal reasons and not due to any disagreements with the Company on any matter related to the operations, policies or practices of the Company.
Chairman and CEO Will Zhang of Antelope Enterprise commented, "We thank Mr. Wang for his contributions to the Company and we wish him the best of success in all of his future endeavors."

Management

AEHL

Antelope Enterprise Announces Its Plan To Launch Energy Transmission Business And Appoints Management Team To Spearhead Such Initiative

<ul>
<li>The portable vital signs monitor (VSM) adds to GE HealthCare's growing Portrait Ecosystem to help clinicians make timely treatment decisions and detect patient deterioration earlier with a streamlined spot check workflow, while ensuring patient mobility.</li>
<li>Portrait VSM uses proven and innovative capabilities to provide precise readings for blood pressure, pulse rate, oxygen saturation, body temperature and respiratory rate.</li>
</ul>
GE HealthCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support timely clinical decisions. As the next evolution of the DINAMAP legacy, Portrait VSM utilizes the SuperSTAT non-invasive blood pressure algorithm to provide precise and accurate measurement readings. Through its wireless connectivity and seamless EMR integration, the portable vital signs monitor was designed with the user workflows in mind, offering customized Early Warning Scores (EWS) and enabling care teams to focus on taking care of their patients by automating routine tasks.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20240429837183/en/">https://www.businesswire.com/news/home/20240429837183/en/</a>
Building on GE HealthCare's family of Portrait monitoring solutions, Portrait VSM can connect with the latest iteration of the Portrait Mobile wireless and wearable continuous monitoring solution to seamlessly integrate patient data in one unified workflow, while ensuring patient mobility. Through a single click of the barcode scanner, Portrait VSM automatically imports the patient demographic data and a snapshot of the patient's continuously monitored data - respiratory rate, oxygen saturation and pulse rate - from Portrait Mobile. This workflow streamlines the process of clinical rounding and reduces the steps needed to capture and chart a complete set of vital sign measurements.
A connected workflow and EMR integration can help enable accurate vital sign charting and eliminate the delay from manual data entry to support clinicians in making timely and confident treatment decisions.1,2 The uninterrupted flow of data and continuous measurement of vital signs, enabled by Portrait Mobile, can also help clinicians detect patient decline as it is happening, enabling timely intervention before a patient deteriorates.
Patients' vital signs are typically measured by traditional spot check methods every 4-6 hours, which can cause early signs of patient deterioration to be missed. Undetected patient deterioration, particularly post-surgery, can lead to hazardous yet preventable consequences, with 30-day mortality after surgery representing the 3rd leading cause of death globally.3 To optimize patient care, Portrait VSM brings together standard spot check capability with continuous patient monitoring through its connectivity to Portrait Mobile.
"We remain focused on tackling healthcare's biggest challenges and driving further efficiencies for care teams through new patient monitoring technology. To help ease the way to more confident care, Portrait VSM offers the clinical performance and capabilities that care teams can trust, so they can spend more valuable time with their patients," said Neal Sandy, general manager, monitoring solutions, GE HealthCare. "With the addition of Portrait VSM, we are excited about this next step for the Portrait Ecosystem that was designed to support the right level of patient monitoring in observational care through a single, unified workflow."
GE HealthCare's <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Finsights%2Freimagining-better-health&amp;esheet=53958743&amp;newsitemid=20240429837183&amp;lan=en-US&amp;anchor=Reimagining+Better+Health&amp;index=1&amp;md5=0821df67a5f4634481fa312904c2a752">Reimagining Better Health</a> study highlighted the burden of inputting and accessing data manually, with nearly half of clinicians reporting that medical technologies at their facilities do not seamlessly integrate with each other.&#x2A; Portrait VSM offers workflow efficiencies and capabilities to support hospitals and care teams in navigating current challenges they're facing. Healthcare systems can incorporate and customize EWS protocols into the monitor view to help clinicians recognize the early signs of deterioration in patients and make timely interventions, while limiting manual calculations and transcription. To enable simplified rounding and help avoid delayed measurements, the Round Advisor feature also helps care teams manage and prioritize spot checks for multiple patients by assigning and tracking a sequence of care.
Built on a well-established history of clinical advancements, GE HealthCare's FlexAcuity monitoring solutions are engineered to adapt to rapidly changing patient needs. GE HealthCare's technology has been recognized globally for its design, receiving the iF Design Gold Award for Product Design in 2022 for Portrait Mobile and an iF Design Award in 2023 for CARESCAPE Canvas.
For more information on Portrait VSM and GE HealthCare's family of Portrait monitoring solutions, please visit: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Fproducts%2Fpatient-monitoring%2Fportrait-vsm&amp;esheet=53958743&amp;newsitemid=20240429837183&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.gehealthcare.com%2Fproducts%2Fpatient-monitoring%2Fportrait-vsm&amp;index=2&amp;md5=f6279cb13f754cd7fbc17d850394ecf8">https://www.gehealthcare.com/products/patient-monitoring/portrait-vsm</a>.
&#x2A;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Finsights%2Freimagining-better-health&amp;esheet=53958743&amp;newsitemid=20240429837183&amp;lan=en-US&amp;anchor=Reimagining+Better+Health&amp;index=3&amp;md5=54d205dbb143c73bc7a237f77e6508a4">Reimagining Better Health</a> survey questions addressed respondents' general perception and experience with technology within their facilities and made no reference to any specific solutions or vendors. References in the study are inclusive of the entire spectrum of medical technology, such as medical devices, software solutions, electronic patient records and other digital workflow solutions.

GEHC

GE HealthCare Receives FDA Clearance For Portrait VSM, Building In Its Growing Ecosystem Of Connected Patient Monitoring Solutions

Ladenburg Thalmann analyst Aydin Huseynov downgrades Acrivon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRV#NASDAQ">ACRV</a>) from Buy to Neutral.

Downgrades

ACRV

Ladenburg Thalmann Downgrades Acrivon Therapeutics to Neutral

Piper Sandler analyst Matthew Clark maintains First Interstate BancSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIBK#NASDAQ">FIBK</a>) with a Overweight and raises the price target from $32 to $37.

FIBK

Piper Sandler Maintains Overweight on First Interstate BancSys, Raises Price Target to $37

Biophytis SA (PARIS:<a class="ticker" href="https://www.benzinga.com/stock/ALBPS#PARIS">ALBPS</a>), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the implementation of a dedicated strategy for partner search in obesity.
Biophytis is continually working on the search for partners thanks to a sound strategy and action plan, with the Company being fully committed to drive groundbreaking scientific and technological advances that have the potential to transform the lives of obese patients worldwide.
Biophytis' partnering strategy is based on the search for the best partners selected through precise targeting and an in-depth analysis and understanding of the pharmaceutical landscape to select the right partners and identify mutual benefits. We are looking to licence-out BI0101 (20-hydroxyecdysones) to regional or global pharmaceutical companies that will co-develop with us the drug candidate up to marketing authorization in the treatment of obesity and other indications and have the capacity to launch and commercialize it in the main regions. BIO101 (20-hydroxyecdysone) is in clinical development (phase 2 OBA study in preparation) in obesity, in combination with GLP-1 receptor agonists (GLP1-RA).
Furthemore, the Company has established a refined and tailored action plan to serve these objective, which includes close collaboration with local agents to provide expertise and network and a Senior Management's presence in the most attractive business events in pharma. For this, Biophytis will attend the BIO US conference, the largest business development conference on the American continent to be held from June 3 to 6 in San Diego.
Stanislas Veillet, CEO of Biophytis, stated: "The obesity market is currently soaring, with the USA (more than 110 million patients), China (approximately 70 million patients) and Brazil (more than 40 million patients) having the highest prevalence rates. It is crucial for Biophytis to position itself in these key regions which are open to innovation and present great potential revenue wise. Beyond the financial aspects, Biophytis has the ambition to address a gigantic medical challenge. But we can't accomplish this on our own. Only by partnering with the brightest minds in science and healthcare can we serve the needs of patients. Biophytis' Partnering strategy is founded on 4 values that will be at the core of our approach: trust, expertise, performance and ambition."

BPTS

PARIS:ALBPS

Biophytis Is Deploying Its Partnership Strategy In Obesity

Piper Sandler analyst Matthew Clark maintains Pacific Premier Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBI#NASDAQ">PPBI</a>) with a Overweight and lowers the price target from $31 to $26.

PPBI

Piper Sandler Maintains Overweight on Pacific Premier Bancorp, Lowers Price Target to $26

Loop Capital analyst Anthony Chukumba upgrades FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) from Hold to Buy and raises the price target from $125 to $140.

FCFS

Loop Capital Upgrades FirstCash Hldgs to Buy, Raises Price Target to $140

Pairing expect to be the first in market with service to remote farms
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.intelsat.com&amp;esheet=53959149&amp;newsitemid=20240429336465&amp;lan=en-US&amp;anchor=Intelsat&amp;index=1&amp;md5=c9236c6a82bd8792832ef277b8ee5bee">Intelsat</a>, operator of one of the world's largest integrated satellite and terrestrial networks, and CNH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>), whose brands include Case IH, New Holland and Steyr, agreed to install, connect and operate ruggedized multi-orbit satellite terminals on CNH farm equipment operating in remote farmland throughout Brazil with Intelsat's global network.
"As the first satellite communications company to provide multi-orbit connectivity to farmers around the world, Intelsat's collaboration with CNH will unlock new capabilities in the most remote locations through our global communications platform," said Dave Wajsgras, CEO of Intelsat. "We've proven that ruggedized, built-for-purpose terminals that can access multiple satellite orbits from anywhere offer the highest network reliability, greater throughput and the best user experience."
Connected smart farms or "precision farming" require robust connectivity to stream data among farm equipment and from the equipment to the cloud. There are over 570 million farms globally, many of which are located in rural locations with poor access to traditional connectivity solutions. In Brazil, for example, less than a quarter of farmland is close enough to a cellular tower to make connection possible. Intelsat FlexMove satellite network is giving end users the reliable connectivity needed to adopt connected equipment and to bring on the next great agricultural revolution.
"Satellite technology helps solve the complex connectivity challenges for hard-to-reach farms, but not all providers are equal. Intelsat stands out for their depth of experience as well as the quality and reliability of their service and industrial terminal offerings. We look forward to serving customers around the world with their solution," said Marc Kermisch, Chief Digital and Information Officer at CNH.
Intelsat and CNH plan to introduce the solution in Brazil in the third quarter of the year. Farming is a large part of the Brazilian economy and Intelsat has invested in infrastructure to provide a new level of service throughout the country.
Intelsat in Brazil:
<ul>
<li>Operations center expansion: Intelsat's Brazil Network Operations Center (NOC) has grown in staff to deliver better support for regional customers, offering 24/7 access to support representatives fluent in five languages including Brazilian Portuguese.</li>
<li>New satellite capacity and teleport: Two satellites positioned over Brazil and Latin America, provide reliable connectivity. Located outside of Rio de Janeiro, the teleport facility expands Intelsat's existing global network and enables direct connections between Intelsat satellites and Brazil's local terrestrial networks to reduce the distance user internet traffic has to travel.</li>
</ul>
For more information, click <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.intelsat.com%2Fnewsroom%2Fintelsat-cnh-smart-farming-satellite-connectivity-coming-to-brazil%2F&amp;esheet=53959149&amp;newsitemid=20240429336465&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=9e49a5665c1d2f6fd1b4759f0e819feb">here</a>.

Global

CNHI

Intelsat, CNH Smart Farming Satellite Connectivity Coming To Brazil

Piper Sandler analyst Scott Siefers maintains First Merchants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRME#NASDAQ">FRME</a>) with a Overweight and raises the price target from $41 to $42.5.

FRME

Piper Sandler Maintains Overweight on First Merchants, Raises Price Target to $42.5

Guardforce AI Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFAI#NASDAQ">GFAI</a>) reported quarterly losses of $(4.53) per share. This is a 69.74 percent increase over losses of $(14.97) per share from the same period last year. The company reported $36.28 million in sales this quarter. This is a 6.82 percent increase over sales of $33.97 million the same period last year.

Earnings

GFAI

Guardforce AI Co FY EPS $(4.53) Up From $(14.97) YoY, Sales $36.28M Up From $33.97M YoY

Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) reported worse-than-expected first-quarter <a href="https://www.benzinga.com/quote/AON/earnings">financial results on Friday</a>.
Aon posted adjusted earnings of $5.66 per share, missing market estimates of $5.91 per share. The company&#8217;s sales came in at $4.070 billion versus expectations of $4.126 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Its operating margin fell 210 basis points to 36.0%, while operating margin, adjusted for certain items, rose 100 basis points to 39.7% during the quarter.
&#8220;Our global team delivered strong operating results in the first quarter, including 5% organic revenue growth, 100 basis points of adjusted operating margin improvement, and 9% adjusted EPS growth&#8221; said Greg Case, Chief Executive Officer. &#8220;We&#8217;re delighted to welcome NFP to Aon and look forward to working together to help clients address increasing volatility across risk and people issues, enabled by Aon Business Services. With this earlier-than-expected close, we&#8217;re moving even faster to address client demand, create more opportunities for our 60,000 colleagues, strengthen the long-term free cash flow profile of the firm, and enhance long-term shareholder value creation.&#8221;
Aon shares fell 6.9% to close at $285.03 on Friday.
These analysts made changes to their price targets on Aon following earnings announcement.
<ul>
<li>Piper Sandler cut the price target on Aon from $326 to $312. Piper Sandler analyst Paul Newsome maintained a Neutral rating.</li>
<li>B of A Securities slashed the price target on Aon from $378 to $345. B of A Securities analyst Joshua Shanker maintained a Neutral rating.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/04/38487215/this-analyst-with-86-accuracy-rate-sees-around-13-upside-in-chipotle-mexican-grill-here-are-5-stock">This Analyst With 86% Accuracy Rate Sees Around 13% Upside In Chipotle Mexican Grill &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>

Aon Analysts Slash Their Forecasts After Downbeat Earnings

European Commission reportedly plans to investigate&nbsp;Meta Platforms Inc&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Facebook and Instagram over concerns regarding Russia disinformation, with suspicions of inadequate moderation.
Regulators are alarmed by Meta&#8217;s purportedly insufficient efforts to combat political advertising disinformation, risking electoral integrity, according to a report from <a href="https://www.ft.com/content/70dc27e8-07bd-40af-8b0e-d4623a3bcc0b" target="_blank" rel="noreferrer noopener">Financial Times</a>.
Also See: <a href="https://www.benzinga.com//node/38481178">How Apple&#8217;s Arch Rivals Meta And Google Are Revamping Their Plans To Take On The Might Of iPhone And Vision Pro</a>
EU officials express unease over Meta&#8217;s handling of Russian interference in upcoming European elections, underlining broader concerns about misinformation spread by foreign entities.
Moreover, the accessibility of Meta&#8217;s content flagging system under the EU&#8217;s Digital Services Act raises apprehensions, with fears that it might not meet regulatory standards.
The investigation, spurred by Meta&#8217;s report on disinformation handling and the EU&#8217;s assessment, will scrutinize whether Facebook and Instagram comply with the law in placing political content.
The probe also delves into Meta&#8217;s discontinuation of CrowdTangle and its tracking methods for disinformation, potentially impacting fact-checkers and journalists.
The report further noted Meta will be given a five-day window to propose mitigation measures, failing which could prompt regulatory actions under the DSA.
Read Next: <a href="https://www.benzinga.com/news/24/04/38458541/metas-threads-enhances-user-control-with-new-features" target="_blank" rel="noreferrer noopener">Meta&#8217;s Threads Enhances User Control with New Features</a>
Meta responded, expressing readiness to cooperate and share further details of its risk mitigation efforts with the European Commission.
The probe follows the imposition of election safeguards by the regulators to mitigate online threats to electoral integrity.
Meta Platforms stock has gained&nbsp;more than&nbsp;82% in the past 12 months. Investors can gain exposure to the stock via&nbsp;The Communication Services Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) and&nbsp;Fidelity MSCI Communication Services Index ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCOM#NYSE">FCOM</a>).
Price Action: META shares are trading lower by 1.1% at $438.44 in premarket at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Credits &#8211; Shutterstock

Equities

Tech

Media

FCOM

Meta Faces EU Probe For Suspected Failure To Combat Russian Disinformation: Report

Piper Sandler analyst Nathan Race maintains First Internet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBK#NASDAQ">INBK</a>) with a Neutral and lowers the price target from $35 to $34.

INBK

Piper Sandler Maintains Neutral on First Internet, Lowers Price Target to $34

FULT

Fulton Financial shares are trading higher after the company priced a $250 million offering of 16,666,667 shares at $15.00 per share.

Barclays analyst Kannan Venkateshwar upgrades AT&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) from Equal-Weight to Overweight and maintains the price target from $20 to $20.

Barclays Upgrades AT&T to Overweight, Maintains Price Target to $20

Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Tuesday, May 19, 2020

Thursday, August 16, 2018